Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Promoter CpG Island Hypermethylation in Dysplastic Naevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy.

Gao L, van den Hurk K, Moerkerk PT, Goeman JJ, Beck S, Gruis NA, van den Oord JJ, Winnepenninckx VJ, van Engeland M, van Doorn R.

J Invest Dermatol. 2014 Jul 7. doi: 10.1038/jid.2014.270. [Epub ahead of print]

PMID:
24999589
[PubMed - as supplied by publisher]
2.

Mycosis fungoides: promoter hypermethylation predicts disease progression.

van Doorn R.

Br J Dermatol. 2014 Jun;170(6):1216. doi: 10.1111/bjd.12870. No abstract available.

PMID:
24947150
[PubMed - in process]
3.

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane.

Commandeur S, Sparks SJ, Chan HL, Gao L, Out JJ, Gruis NA, van Doorn R, El Ghalbzouri A.

Melanoma Res. 2014 Aug;24(4):305-14. doi: 10.1097/CMR.0000000000000079.

PMID:
24892959
[PubMed - in process]
4.

The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review.

Peto L, Nadjm B, Horby P, Ngan TT, van Doorn R, Van Kinh N, Wertheim HF.

Trans R Soc Trop Med Hyg. 2014 Jun;108(6):326-37. doi: 10.1093/trstmh/tru058. Epub 2014 Apr 29.

PMID:
24781376
[PubMed - in process]
Free PMC Article
5.

Near-genomewide RNAi screening for regulators of BRAF(V600E) -induced senescence identifies RASEF, a gene epigenetically silenced in melanoma.

Kaplon J, Hömig-Hölzel C, Gao L, Meissl K, Verdegaal EM, van der Burg SH, van Doorn R, Peeper DS.

Pigment Cell Melanoma Res. 2014 Jul;27(4):640-52. doi: 10.1111/pcmr.12248. Epub 2014 May 14.

PMID:
24703243
[PubMed - in process]
6.

Twelve-week Treatment of Lentigo Maligna with Imiquimod Results in a High and Sustained Clearance Rate.

Kirtschig G, van Meurs T, van Doorn R.

Acta Derm Venereol. 2014 Apr 3. doi: 10.2340/00015555-1861. [Epub ahead of print]

PMID:
24696093
[PubMed - as supplied by publisher]
Free Article
7.

Inherited variation in the PARP1 gene and survival from melanoma.

Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Sivaramakrishna Rachakonda P, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Timothy Bishop D, Newton-Bishop J.

Int J Cancer. 2014 Oct 1;135(7):1625-33. doi: 10.1002/ijc.28796. Epub 2014 Mar 6.

PMID:
24535833
[PubMed - in process]
8.

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study.

Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Guan J, Sivaramakrishna Rachakonda P, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, Newton-Bishop J.

Pigment Cell Melanoma Res. 2014 Mar;27(2):234-43. doi: 10.1111/pcmr.12193. Epub 2013 Dec 11.

PMID:
24219834
[PubMed - in process]
Free PMC Article
9.

Sample preparation for combined chemical analysis and in vitro bioassay application in water quality assessment.

Kolkman A, Schriks M, Brand W, Bäuerlein PS, van der Kooi MM, van Doorn RH, Emke E, Reus AA, van der Linden SC, de Voogt P, Heringa MB.

Environ Toxicol Pharmacol. 2013 Nov;36(3):1291-303. doi: 10.1016/j.etap.2013.10.009. Epub 2013 Oct 23.

PMID:
24216068
[PubMed - indexed for MEDLINE]
10.

[A woman with paraneoplastic dermatoses; signs of recurrent malignancy].

Quint KD, Edelbroek JR, Gelderblom AJ, van Doorn R, Vermeer MH.

Ned Tijdschr Geneeskd. 2013;157(38):A6560. Dutch.

PMID:
24050449
[PubMed - indexed for MEDLINE]
11.

Class III β-tubulin, a novel biomarker in the human melanocyte lineage.

Locher H, de Rooij KE, de Groot JC, van Doorn R, Gruis NA, Löwik CW, Chuva de Sousa Lopes SM, Frijns JH, Huisman MA.

Differentiation. 2013 Apr-Jun;85(4-5):173-81. doi: 10.1016/j.diff.2013.05.003. Epub 2013 Jul 2.

PMID:
23817083
[PubMed - indexed for MEDLINE]
12.

Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study.

Zebary A, Omholt K, van Doorn R, Ghiorzo P, Harbst K, Hertzman Johansson C, Höiom V, Jönsson G, Pjanova D, Puig S, Scarra GB, Harland M, Olsson H, Egyhazi Brage S, Palmer J, Kanter-Lewensohn L, Vassilaki I, Hayward NK, Newton-Bishop J, Gruis NA, Hansson J; Melanoma Genetics Consortium (GenoMEL).

J Invest Dermatol. 2014 Jan;134(1):287-90. doi: 10.1038/jid.2013.270. Epub 2013 Jun 14. No abstract available.

PMID:
23771122
[PubMed - indexed for MEDLINE]
13.

Eruptive melanocytic naevi as a sign of primary adrenocortical insufficiency.

Koelemij I, Massolt ET, van Doorn R.

Clin Exp Dermatol. 2013 Dec;38(8):927-9. doi: 10.1111/ced.12133. Epub 2013 May 21. No abstract available.

PMID:
23692464
[PubMed - indexed for MEDLINE]
14.

Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma.

Gao L, Smit MA, van den Oord JJ, Goeman JJ, Verdegaal EM, van der Burg SH, Stas M, Beck S, Gruis NA, Tensen CP, Willemze R, Peeper DS, van Doorn R.

Pigment Cell Melanoma Res. 2013 Jul;26(4):542-54. doi: 10.1111/pcmr.12096. Epub 2013 Apr 17.

PMID:
23590314
[PubMed - indexed for MEDLINE]
15.

[Vismodegib in metastasized basal cell carcinoma].

Reinders MG, Dirix L, Mosterd K, van Doorn R.

Ned Tijdschr Geneeskd. 2013;157(12):A6011. Dutch.

PMID:
23515044
[PubMed - indexed for MEDLINE]
16.

HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome.

Wardwell-Ozgo J, Dogruluk T, Gifford A, Zhang Y, Heffernan TP, van Doorn R, Creighton CJ, Chin L, Scott KL.

Oncogene. 2014 Feb 20;33(8):1017-26. doi: 10.1038/onc.2013.30. Epub 2013 Feb 25.

PMID:
23435427
[PubMed - indexed for MEDLINE]
17.

Array-CGH analysis of cutaneous anaplastic large cell lymphoma.

Szuhai K, van Doorn R, Tensen CP, Van Kester.

Methods Mol Biol. 2013;973:197-212. doi: 10.1007/978-1-62703-281-0_13.

PMID:
23412792
[PubMed - indexed for MEDLINE]
18.

Genome-wide analysis of gene and protein expression of dysplastic naevus cells.

Gao L, van Nieuwpoort FA, Out-Luiting JJ, Hensbergen PJ, de Snoo FA, Bergman W, van Doorn R, Gruis NA.

J Skin Cancer. 2012;2012:981308. doi: 10.1155/2012/981308. Epub 2012 Nov 28.

PMID:
23251804
[PubMed]
Free PMC Article
19.

Successful fixation of Mason type 2 radial head fractures using Meniscus Arrows.

Ottink DA, van Zutphen SW, van Doorn R, Wouters DB.

Knee Surg Sports Traumatol Arthrosc. 2014 Jan;22(1):49-52. doi: 10.1007/s00167-012-2193-1. Epub 2012 Sep 13.

PMID:
22972313
[PubMed - in process]
20.

MetiTree: a web application to organize and process high-resolution multi-stage mass spectrometry metabolomics data.

Rojas-Chertó M, van Vliet M, Peironcely JE, van Doorn R, Kooyman M, te Beek T, van Driel MA, Hankemeier T, Reijmers T.

Bioinformatics. 2012 Oct 15;28(20):2707-9. doi: 10.1093/bioinformatics/bts486. Epub 2012 Jul 31.

PMID:
22851531
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk